Compass Therapeutics's total assets for Q1 2025 were $131.45M, a decrease of -6.38% from the previous quarter. CMPX total liabilities were $21.17M for the fiscal quarter, a 39.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.